论著

改良高通量测序分析策略诊断儿童期发病亨廷顿舞蹈病及其临床特征分析

  • 徐诗怡 ,
  • 刘怡 ,
  • 余永国 ,
  • 干静 ,
  • 肖冰 ,
  • 孙昱
展开
  • 1.上海交通大学医学院附属新华医院 上海市儿科医学研究所(上海 200092)
    2.上海交通大学医学院附属新华医院神经内科(上海 200092)

收稿日期: 2024-12-26

  录用日期: 2025-04-22

  网络出版日期: 2025-06-01

基金资助

国家重点研发计划(2022YFC2703404);国家自然科学基金面上项目(82070914);国家自然科学基金面上项目(82271904);上海市自然科学基金面上项目(22ZR1451400);上海市自然科学基金面上项目(23ZR1452700)

Optimized high-throughput sequencing for diagnosing childhood-onset Huntington's disease and analysis of clinical features

  • XU Shiyi ,
  • LIU Yi ,
  • YU Yongguo ,
  • GAN Jing ,
  • XIAO Bing ,
  • SUN Yu
Expand
  • 1. Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute for Pediatric Research, Shanghai 200092, China
    2. Department of Neurology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, China

Received date: 2024-12-26

  Accepted date: 2025-04-22

  Online published: 2025-06-01

摘要

目的 报告1例儿童期发病亨廷顿病(COHD)患儿的临床特征及遗传改变,探讨改良高通量测序数据分析方法检出CAG重复扩增变异的可能。方法 经外显子组测序(ES)STR分析(ES-STR)发现1例COHD病例,回顾性分析该患儿的临床资料,总结COHD的遗传学和表型特征。结合大规模临床ES数据,分析基于ES数据对HTT(CAG)n扩增的检测效果。结果 先证者,男,16岁,主要临床表现为言语发育迟缓、运动倒退、行走不稳。通过分析ES结果发现患儿HuntingtonHTT)基因上(CAG)n重复拷贝数为83/17,家系验证结果发现患儿父亲HTT基因上(CAG)n重复拷贝数分别为44/18。文献检索共纳入15篇文献,共20例患儿,临床表现主要以言语迟缓、运动障碍、肌张力障碍为主,平均发病年龄(4.23±2.33)岁,(CAG)n 重复拷贝数范围为51~312次。ES在HTT(CAG)n位点覆盖较好,可以有效的将CAG重复数超过病理阈值的病例检测出来,但是随着CAG重复数目增加,检测出的CAG数目和实际出现偏差,还需依赖验证时得出准确的重复数。结论 ES-STR对于亨廷顿舞蹈症是一种有效的诊断方法,特别对于临床表型不典型的COHD患儿,在高通量测序方法中即可有效分析诊断,本文通过归纳COHD患儿的临床表现,以助于临床诊断,避免误诊、漏诊发生。

本文引用格式

徐诗怡 , 刘怡 , 余永国 , 干静 , 肖冰 , 孙昱 . 改良高通量测序分析策略诊断儿童期发病亨廷顿舞蹈病及其临床特征分析[J]. 临床儿科杂志, 2025 , 43(6) : 445 -451 . DOI: 10.12372/jcp.2025.24e1388

Abstract

Objective To report the clinic characteristic and genetic variant of a patient with childhood-onset Huntington disease (COHD), investigate the possibility of enhanced next-generation sequencing data to detect CAG repeat expansion and increase the outstanding of the disease through literature review. Method A COHD case was identified by exome sequencing combined with STR analysis (ES-STR), and the genetic and clinical date of the COHD patient were analyzed. Results The proband, a 16-year-old boy, presented with speech delay, hypokinesia and unsteady walking. ES analysis revealed 83 CAG repeats in Huntington gene (HTT) inherited from his father with 44 CAG repeats in HTT. In total, 15 articles and 20 patients related to COHD were included in literature review. Speech delay, dyskinesia, dystonia were major manifestations. The average onset was (4.23±2.33) years and the range of CAG repeat number of HTT gene was 51-312. ES demonstrated adequate coverage in the HTT locus and could identified cases with pathogenic expansion while large expansion needs additional validation to determine the precise repeat length. Conclusion The patient with COHD tended to have speech delay and movement disorder as the initial symptom instead of involuntary choreiform movements. ES-STR is an efficient diagnosis for Huntington disease (HD), particularly in COHD exhibiting non-classical phenotype. This article summarized the clinical features of COHD to improve the diagnosis for this rare disease and avoid undiagnosis and misdiagnosis.

参考文献

[1] Shafie A, Ashour AA, Anwar S, et al. Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease[J]. Arch Pharm Res, 2024, 47(6): 571-595.
[2] Marcus R. What is Huntington disease?[J]. JAMA, 2023, 330(10): 1014.
[3] Yang K, Quiroz V, Tam A, et al. Juvenile-onset Huntington’s disease - Spectrum and evolution of presenting movement disorders[J]. Ann Clin Transl Neurol, 2024, 11(10): 2805-2810.
[4] Oosterloo M, Touze A, Byrne LM, et al. Clinical review of juvenile Huntington’s disease[J]. J Huntingtons Dis, 2024, 13(2): 149-161.
[5] Baizabal-Carvallo JF, Cardoso F. Chorea in children: etiology, diagnostic approach and management[J]. J Neural Transm (Vienna), 2020, 127(10): 1323-1342.
[6] Dolzhenko E, Van Vugt JJFA, Shaw RJ, et al. Detection of long repeat expansions from PCR-free whole-genome sequence data[J]. Genome Res, 2017, 27(11): 1895-1903.
[7] Dolzhenko E, Bennett MF, Richmond PA, et al. Expansion hunter denovo: a computational method for locating known and novel repeat expansions in short-read sequencing data[J]. Genome Biol, 2020, 21(1): 102.
[8] Mckenna A, Hanna M, Banks E, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data[J]. Genome Res, 2010, 20(9): 1297-1303.
[9] Sun Y, Ye X, Fan Y, et al. High detection rate of copy number variations using capture sequencing data: a retrospective study[J]. Clin Chem, 2020, 66(3): 455-462.
[10] Geoffroy V, Herenger Y, Kress A, et al. AnnotSV: an integrated tool for structural variations annotation[J]. Bioinformatics, 2018, 34(20): 3572-3574.
[11] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424.
[12] Dolzhenko E, Weisburd B, Iba?ez K, et al. REViewer: haplotype-resolved visualization of read alignments in and around tandem repeats[J]. Genome Med, 2022, 14(1): 84.
[13] 王秀英, 彭炳蔚, 朱海霞, 等. 儿童期起病的亨廷顿病1例报告[J]. 癫痫与神经电生理学杂志, 2024, 33(1): 60-63.
  Wang XY, Peng BW, Zhu HX et al. Juvenile Huntington’s disease: a case report[J]. Dianxian Yu Shenjingdianshenglixue ZaZhi, 2024, 33(1): 60-63.
[14] 侯梅, 孙殿荣, 于荣, 等. Westphal变异型亨廷顿病一例[J]. 中华儿科杂志, 2012, 50(12): 953-954.
  Hou M, Sun DR, Yu R, et al. Westphal variant Huntington′s disease in a case[J]. Zhonghua Erke Zazhi. 2012, 50(12): 953-954.
[15] Gauto A, Bellantonio E, Pedernera-Bradichansky P, et al. Childhood-onset Huntignton′s disease. A rare presentation[J]. Rev Neurol, 2024, 78(5): 135-138.
[16] Im DH, Borchert MS, Chang MY. Delayed diagnosis of childhood-onset huntington disease in an 8-year-old boy with ocular motor apraxia[J]. J Neuroophthalmol, 2023, 43(4): e304.
[17] Patra KC, Shirolkar MS. Childhood-onset (juvenile) Huntington’s disease: a rare case report[J]. J Pediatr Neurosci, 2015, 10(3): 276-279.
[18] Vargas AP, Carod-Artal FJ, Bomfim D, et al. Unusual early-onset Huntington’s disease[J]. J Child Neurol, 2003, 18(6): 429-432.
[19] Gencik M, Hammans C, Strehl H, et al. Chorea Huntington: a rare case with childhood onset[J]. Neuropediatrics, 2002, 33(2): 90-92.
[20] Angelini L, Sgrò V, Erba A, et al. Tourettism as clinical presentation of Huntington’s disease with onset in childhood[J]. Ital J Neurol Sci, 1998, 19(6): 383-385.
[21] Powis Z, Lutz J, Liaquat K, et al. Expanding the phenotype of extremely early onset juvenile Huntington’s disease: a case report and review of previously published cases[J]. Am J Med Genet A, 2025, 97(3): e63894.
[22] Moeller AA, Felker MV, Brault JA, et al. Patients with extreme early onset juvenile Huntington disease can have delays in diagnosis: a case report and literature review[J]. Child Neurol Open, 2021, 8: 2329048X211036137.
[23] Milunsky JM, Maher TA, Loose BA, et al. XL PCR for the detection of large trinucleotide expansions in juvenile Huntington’s disease[J]. Clin Genet, 2003, 64(1): 70-73.
[24] Nicolas G, Devys D, Goldenberg A, et al. Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume[J]. Am J Med Genet A, 2011, 155A(4): 815-818.
[25] Yoon G, Kramer J, Zanko A, et al. Speech and language delay are early manifestations of juvenile-onset Huntington disease[J]. Neurology, 2006, 67(7): 1265-1267.
[26] Rossi Sebastiano D, Soliveri P, Panzica F, et al. Cortical myoclonus in childhood and juvenile onset Huntington’s disease[J]. Parkinsonism Relat Disord, 2012, 18(6): 794-797.
[27] Letort D, Gonzalez-Alegre P. Huntington’s disease in children[J]. Handb Clin Neurol, 2013, 113: 1913-1917.
[28] Bakels HS, Roos RAC, Roon-Mom WMC van, et al. Juvenile-onset Huntington disease pathophysiology and neurodevelopment: a review[J]. Mov Disord, 2022, 37(1): 16-24.
[29] Tramutola A, Bakels HS, Perrone F, et al. GLUT-1 changes in paediatric Huntington disease brain cortex and fibroblasts: an observational case-control study[J]. EBioMedicine, 2023, 97: 104849.
[30] Green RC, Berg JS, Grody WW, et al. ACMG recom-mendations for reporting of incidental findings in clinical exome and genome sequencing[J]. Genet Med, 2013, 15(7): 565-574.
[31] Miller DT, Lee K, Abul-Husn NS, et al. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)[J]. Genet Med, 2023, 25(8):100866.
[32] 李小丽, 张晓莉, 李肖, 等. STXBP1基因相关脑病患儿的临床表型和基因变异分析[J]. 临床儿科杂志, 2024, 42(2): 127-132.
  Li XL, Zhang XL, Li X, et al. Clinical phenotypes and gene mutations analysis of children with STXBP1 gene-related encephalopathy[J]. Linchuang Erke Zazhi, 2024, 42(2): 127-132.
[33] 夏秦, 顾琴, 陈婷, 等. DDX3X基因变异致X连锁智力障碍3例临床分析及康复随访[J]. 临床儿科杂志, 2024, 42(11): 948-954.
  Xia Q, Gu Q, Chen T, et al. Clinical analysis and follow-up of rehabilitation training of X-linked intellectual disability caused by DDX3X gene variation: a report of three cases[J]. Linchuang Erke Zazhi, 2024, 42(11): 948-954.
文章导航

/